Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers, Version 6.0 (October 2023) Available online: http://www.survivorshipguidelines.org Click under Health Links for: Endocrine System: Central Adrenal Insufficiency, Growth Hormone Deficiency, Hyperprolactinemia, Hypopituitarism, Precocious Puberty, Thyroid Cancer

Chemaitilly W, Li Z, Brinkman TM, et al. (2022). Primary hypothyroidism in childhood cancer survivors: Prevalence, risk factors, and long-term consequences. Cancer, 128(3), 606-614. https://doi.org/10.1002/cncr.33969

Chemaitilly W, Liu Q, Van Iersel L, et al. (2019). Leydig Cell Function in Male Survivors of Childhood Cancer: A Report from the St Jude Lifetime Cohort Study. Journal of Clinical Oncology, 37 (32), 3018-3031. doi: 10.1200/JCO.19.00738.

Chemaitilly W, Li Z, Krasin MJ, et al: (2017) Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime Cohort. J Clin Endocrinol Metab 102(7):2242-50, 2017.

DeMayo FJ, Zhao B, Takamoto N, & Tsai SY. (2002). Mechanisms of action of estrogen and progesterone. Annals of the New York Academy of Sciences, 955, 48–406. https://doi.org/10.1111/j.1749-6632.2002.tb02765.x

Eugster EA. (2019) Treatment of Central Precocious Puberty. (2019) J Endocr Soc. 2019;3(5):965-972. Published 2019 Mar 28. doi:10.1210/js.2019-00036

Khaddour K, Hana CK, Mewawalla P. (2023) Hematopoietic Stem Cell Transplantation. [Updated 2023 May 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536951/

Kota AS, Ejaz S. Precocious Puberty. [Updated 2023 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544313/

Nyström A, Mörse H, Nordlöf H, et al. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment. Acta Oncol 58(2):218-24, 2019

Raman S, Grimberg A, Waguespack SG, et al. (2015) Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy—A Report from the Pediatric Endocrine Society Drug and Therapeutics Committee, The Journal of Clinical Endocrinology & Metabolism, Volume 100, Issue 6, 1 June 2015, Pages 2192–2203, https://doi.org/10.1210/jc.2015-1002

Sklar CA, Antal Z, Chemaitilly W, et al: Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 1;103(8):2761-2784, 2018